600998.SH
九州通
SSE · Healthcare · Medical - Distribution · CN
CNY 4.92
+0.20%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 164.2B | 161.4B | 151.8B | 150.1B | 140.4B |
| Cost of Revenue | 151.3B | 148.8B | 140.0B | 138.0B | 129.5B |
| Gross Profit | 12.8B | 12.5B | 11.8B | 12.1B | 10.9B |
| Operating Expenses | |||||
| R&D Expense | 117.0M | 128.8M | 146.7M | 196.6M | 178.4M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 3.2B | 3.1B | 2.9B | 2.8B | 2.5B |
| Selling & Marketing Expense | 5.1B | 5.0B | 4.4B | 4.4B | 4.1B |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 9.8B | 9.6B | 9.0B | 9.0B | 8.3B |
| Cost and Expenses | 161.1B | 158.4B | 149.0B | 147.1B | 137.8B |
| Operating Income (EBIT) | 2.8B | 3.3B | 3.6B | 3.0B | 2.9B |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 2.8B | 3.3B | 3.6B | 3.0B | 2.8B |
| Income Tax Expense | 786.0M | 880.2M | 851.0M | 701.2M | 552.6M |
| Bottom Line | |||||
| Net Income | 2.0B | 2.3B | 2.5B | 2.2B | 2.1B |
| Earnings from Cont. Ops | 2.0B | 2.4B | 2.8B | 2.3B | 2.3B |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 2.0B | 2.3B | 2.5B | 2.2B | 2.1B |
| Per Share | |||||
| Basic EPS | CN¥0.39 | CN¥0.44 | CN¥0.50 | CN¥0.43 | CN¥0.51 |
| Diluted EPS | CN¥0.39 | CN¥0.44 | CN¥0.50 | CN¥0.43 | CN¥0.51 |
| Revenue Per Share | CN¥31.35 | CN¥31.49 | CN¥30.27 | CN¥29.70 | CN¥34.35 |
| Shares | |||||
| Basic Shares Outstanding | 5.2B | 5.1B | 5.0B | 5.1B | 4.1B |
| Diluted Shares Outstanding | 5.2B | 5.1B | 5.0B | 5.1B | 4.1B |
| Profitability Metrics | |||||
| EBITDA | — | 4.0B | 4.4B | 3.7B | 3.5B |
| D&A | — | 740.1M | 791.6M | 718.5M | 672.7M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026